- We will send in 10–14 business days.
/images/books/9840815/9781439814482.jpg)
- Author: Angela Smith
- Publisher: CRC Press
- ISBN-10: 1439814481
- ISBN-13: 9781439814482
- Format: 15.8 x 23.6 x 2.3 cm, kieti viršeliai
- Language: English
- SAVE -10% with code: EXTRA
Reviews
Description
The third edition of the bestselling Clinical Trials in Oncology provides a concise, nontechnical, and thoroughly up-to-date review of methods and issues related to cancer clinical trials. The authors emphasize the importance of proper study design, analysis, and data management and identify the pitfalls inherent in these processes. In addition, the book has been restructured to have separate chapters and expanded discussions on general clinical trials issues, and issues specific to Phases I, II, and III. New sections cover innovations in Phase I designs, randomized Phase II designs, and overcoming the challenges of array data.
Although this book focuses on cancer trials, the same issues and concepts are important in any clinical setting. As always, the authors use clear, lucid prose and a multitude of real-world examples to convey the principles of successful trials without the need for a strong statistics or mathematics background. Armed with Clinical Trials in Oncology, Third Edition, clinicians and statisticians can avoid the many hazards that can jeopardize the success of a trial.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 22d.07:17:48
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Angela Smith
- Publisher: CRC Press
- ISBN-10: 1439814481
- ISBN-13: 9781439814482
- Format: 15.8 x 23.6 x 2.3 cm, kieti viršeliai
- Language: English English
The third edition of the bestselling Clinical Trials in Oncology provides a concise, nontechnical, and thoroughly up-to-date review of methods and issues related to cancer clinical trials. The authors emphasize the importance of proper study design, analysis, and data management and identify the pitfalls inherent in these processes. In addition, the book has been restructured to have separate chapters and expanded discussions on general clinical trials issues, and issues specific to Phases I, II, and III. New sections cover innovations in Phase I designs, randomized Phase II designs, and overcoming the challenges of array data.
Although this book focuses on cancer trials, the same issues and concepts are important in any clinical setting. As always, the authors use clear, lucid prose and a multitude of real-world examples to convey the principles of successful trials without the need for a strong statistics or mathematics background. Armed with Clinical Trials in Oncology, Third Edition, clinicians and statisticians can avoid the many hazards that can jeopardize the success of a trial.
Reviews